William L. Miller

发表

Polychromatic flow cytometry: A rapid method for the reduction and analysis of complex multiparameter data

Daniel Haley, Kevin Floyd, William Miller, 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

OX40 is a potent immune-stimulating target in late-stage cancer patients.

B. Fox, N. Morris, T. Crocenzi, 2013, Cancer research.

Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG

E. Walker, A. Weinberg, B. Curti, 2012, European journal of immunology.

Characterization of the Class I-Restricted gp100 Melanoma Peptide-stimulated Primary Immune Response in Tumor-Free Vaccine-draining Lymph Nodes and Peripheral Blood

W. Urba, E. Walker, B. Curti, 2009, Clinical Cancer Research.

Combined IL-21 and Low-Dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model

W. Alvord, B. Fox, W. Urba, 2006, Journal of Translational Medicine.

gp100209–2M Peptide Immunization of Human Lymphocyte Antigen-A2+ Stage I-III Melanoma Patients Induces Significant Increase in Antigen-Specific Effector and Long-Term Memory CD8+ T Cells

W. Alvord, B. Fox, H. Maecker, 2004, Clinical Cancer Research.

Induction of Circulating Tumor-reactive CD8+ T Cells After Vaccination of Melanoma Patients With the gp100209-2M Peptide

B. Fox, P. Romero, S. Meijer, 2007, Journal of immunotherapy.

gp 100209 – 2 M Peptide Immunization of Human Lymphocyte Antigen-A 2 Stage I-III Melanoma Patients Induces Significant Increase in Antigen-Specific Effector and Long-Term Memory CD 8 T Cells

W. Alvord, B. Fox, H. Maecker, 2004 .

Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses

W. Urba, E. Walker, J. Siebert, 2012, Science Translational Medicine.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Phenotype and Functional Characterization of Long-term gp100-Specific Memory CD8+ T Cells in Disease-Free Melanoma Patients Before and After Boosting Immunization

B. Fox, G. Alvord, W. Urba, 2008, Clinical Cancer Research.

A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood

Y. Koguchi, D. Haley, William L. Miller, 2016, Journal of visualized experiments : JoVE.

OX40 is a potent immune-stimulating target in late-stage cancer patients.

B. Fox, N. Morris, T. Crocenzi, 2013, Cancer research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.